{"id":"https://openalex.org/A5048899239","orcid":"https://orcid.org/0009-0009-6425-5372","observed_orcids":["https://orcid.org/0009-0009-6425-5372"],"display_name":"Yuxin Dai","raw_author_names":["Y. Dai","Yuxin Dai"],"full_name":"Yuxin Dai","works_count":4,"cited_by_count":26,"summary_stats":{"2yr_mean_citedness":8.666666666666666,"h_index":2,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5048899239","orcid":"https://orcid.org/0009-0009-6425-5372","observed_orcids":["https://orcid.org/0009-0009-6425-5372"]},"affiliations":[{"institution":{"id":"https://openalex.org/I173899330","ror":"https://ror.org/003xyzq10","display_name":"Henan University","country_code":"CN","type":"education","lineage":["https://openalex.org/I173899330"]},"years":[2025]},{"institution":{"id":"https://openalex.org/I58200834","ror":"https://ror.org/01vjw4z39","display_name":"Southern Medical University","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]},"years":[2026,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I58200834","ror":"https://ror.org/01vjw4z39","display_name":"Southern Medical University","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":2,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","count":1,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10515","display_name":"Cancer-related molecular mechanisms research","count":1,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","value":1.46e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11482","display_name":"RNA modifications and cancer","value":1.14e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","value":7.4e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","value":7.2e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","value":6.1e-06,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.6966999769210815},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.5849999785423279},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.5004000067710876},{"id":"167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","score":0.43664199113845825},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.36613014340400696}],"counts_by_year":[{"year":2019,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":2},{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":21},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":3}],"display_name_alternatives":["Y. Dai","Yuxin Dai"],"block_key":"y dai","works_api_url":"https://api.openalex.org/works?filter=author.id:A5048899239","updated_date":"2026-10-13T12:33:52","created_date":"2025-10-10T00:00:00"}